Laboratory Perspective of Concurrent Acute Myeloid Leukemia and COVID-19: a Case Report and Review of Literature.
Clin Lab
; 68(11)2022 Nov 01.
Article
em En
| MEDLINE
| ID: mdl-36378007
ABSTRACT
BACKGROUND:
Whether the diagnosis and treatment of coronavirus disease 2019 (COVID-19) affect the clinical course of patients with hematologic malignancies has been of interest during the COVID-19 pandemic.METHODS:
We describe a 47-year-old female who was concurrently diagnosed with COVID-19 and acute myeloid leukemia (AML).RESULTS:
She developed COVID-19 pneumonia which required treatment with remdesivir and dexamethasone, and induction therapy for t-AML was delayed. After her COVID-19 was resolved and isolation ended, follow-up bone marrow examination showed decreased leukemic burden.CONCLUSIONS:
This case describes possible effects of COVID-19 treatment on the clinical course of patients with AML from a laboratory perspective.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Leucemia Mieloide Aguda
/
COVID-19
Tipo de estudo:
Diagnostic_studies
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Revista:
Clin Lab
Assunto da revista:
TECNICAS E PROCEDIMENTOS DE LABORATORIO
Ano de publicação:
2022
Tipo de documento:
Article